We are monitoring the impact of COVID-19 on Monoclonal Antibodies Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 1119
Share on
Share on

Global Monoclonal Antibodies (mABs) Market Analysis - By Source, Indication, End-User, Application (Medical, Experimental, Western (Blot, ELISA, Radioimmune Assays, Immunofluorescence & others), By Region - Size, Share, Trends, Growth Opportunities Assessment, Industry Forecast | 2019 – 2024

Pulished: August, 2019
ID: 1119
Pages: 179

Global mABs Market Size and Industry Analysis (2019 to 2024)

As per our report, the size of the global monoclonal antibodies market was worth USD 37.13 Billion in 2019. This figure is estimated to be growing at a CAGR of 5.30% and will reach USD 63.13 Billion by 2024.

In biochemistry and molecular biology, monoclonal antibodies play an important role as they can detect or purify substances. In general, these are derived from the identical immune cells and can easily bind to a particular antigen. Hybridoma technology is designing monoclonal antibodies where this will enhance the immunity system naturally. It is approved by the U.S Food and Drug Administration (FDA) as it is an innovative product in the molecular biology for disease treatment. Many global companies are focusing on the development of the molecular agents which will use for the treatment of various diseases like cancer. 

MARKET DRIVERS

Increasing incidences of chronic diseases such as cancer, diabetes, and others across the world is undoubtedly a key factor for the worldwide monoclonal antibodies market to grow. The rise in the demand to ensure quality services in healthcare is additionally accelerating the need of the market. Also, the invention of new applications in monoclonal antibodies is significantly influencing the growth rate of this market to the extent. The rise in the investments in the improvement of healthcare infrastructure is likely to boost up the demand of the global mABs market. The development of new molecules is expected to play a prominent role in the future of the market due to the cost-effectiveness of this technology.

The advancement of genomics research and development activities, as well as the emergence of technologically advanced genetic platforms, such as the next-generation sequencing, has contributed significantly to the market and helping the existing companies in the global mABs market to grow further.

The emergence of advance technology and the launch of innovative products in the biotechnology field and growth in the economy in both developed and developing countries are surging the demand of the monoclonal antibodies market. Growing knowledge over genomics and trend towards next-generation sequencing and ease in the availability of various resources used in the research centres are fueling the demand of the market. The rise in the awareness over the therapies and other biological parameters are impacting positively on the growth of the market.

MARKET RESTRAINTS

However, less availability of raw materials used for the manufacturing of drugs is restraining the demand of the market. Lack of sufficient knowledge in rural areas is slowly to hinder the growth rate of the market.

Some of the other major challenging factors for the monoclonal antibodies market is the shortage of skilled labour. It is due to less training programs in the biotechnology field. The equipment used in the laboratories is high in cost where small scale organizations cannot afford them, which is also one of the factors impeding the demand of the mABs market.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2018 to 2024

Base Year

2018

Forecast Period

2019 to 2024

Segments Covered

By Source, Indication, End User, Application and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on Global Monoclonal Antibodies Market has been segmented and sub-segmented based on the source, indication, end-user, application and region.

Monoclonal Antibodies Market - By Source

  • Murine
  • Chimeric
  • Humanized
  • Human

Based on the source, the murine segment is holding the highest shares of the global monoclonal antibodies market, whereas chimeric is to have the highest growth rate in the coming years. An increasing number of people suffering from various health disorders is a specific factor for this segment to grow.

Monoclonal Antibodies Market - By Indication

  • Cancer
    • Blood Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Lung Cancer
    • Pancreatic Cancer
    • Others
  • Autoimmune Diseases
  • Infectious Diseases
  • Cardiovascular Diseases
  • CNS Disorders
  • Others (Inflammatory, Microbial Diseases, & Other)

Based on indication, the cancer disease segment is ruling with dominant shares of the global mABs market. Adoption of sedentary lifestyles and changes in food habits are some of the attributes for cancer diseases category to grow.

Monoclonal Antibodies Market - By End-User

  • Hospitals/Clinics
  • Research Institute
  • Diagnostic Laboratories

Based on end-user, Hospitals/clinics have the most significant shares in the market by owing to the increase in the scale of healthcare centres and clinics. Besides, the growing geriatric population is enhancing the growth rate of the market.

Monoclonal Antibodies Market - By Application

  • Medical
  • Experimental
  • Western Blot
    • ELISA
    • Radioimmune Assays
    • Immunofluorescence
    • Others

Based on application, the medical segment is holding dominant shares of the global monoclonal antibodies market due to a rise in the number of research and development activities.

Regional Analysis:

North America is dominating the market due to the existence of well-established health care infrastructure in this region, the increased importance given to state infection control and management and the growing prevalence of lifestyle-related health issues. During the forecast period, the market will continue to grow, owing to amplified public investments for cancer research and technological development.

Asia-Pacific market segment is also anticipated to increase significantly due to improved lifestyles of people and increasing awareness about mAbs among patients, increased research and development costs. Due to the lack of penetration, the Asia Pacific market has a high potential to grow during the forecast period.

TOP COMPANIES IN THE MARKET

Companies leading the global monoclonal antibodies market profiled in the report are GlaxoSmithKline PLC, Novartis AG, Pfizer Inc., Thermo Fisher Scientific Inc., Eli Lilly and Company, Seattle Genetics, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd. And Shanghai Junshi Bioscience Co., Ltd.

RECENT MARKET DEVELOPMENTS

In January 2020, Pfizer has announced to launch Bavencio (avelumab) vaccine which is used to treat cancer patients.

In February 2020, GlaxoSmithKline plc has registered to introduce belantamab mafodotin which will act upon the B-cell maturation antigen.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Source                    

                                5.1.1 Murine     

                                5.1.2 Chimeric  

                                5.1.3 Humanized             

                                5.1.4 Human     

                5.2 By Indication                              

                                5.2.1 Cancer      

                                                5.2.1.1 Blood Cancer

                                                5.2.1.2 Breast Cancer

                                                5.2.1.3 Colorectal Cancer

                                                5.2.1.4 Lung Cancer

                                                5.2.1.5 Pancreatic Cancer

                                                5.2.1.6 Others

                                5.2.2 Autoimmune Diseases       

                                5.2.3 Infectious Diseases             

                                5.2.4 Cardiovascular Diseases    

                                5.2.5 CNS Disorders       

                                5.2.6 Others (Inflammatory, Microbial Diseases, & Other)             

                5.3 End User                     

                                5.3.1 Hospitals/Clinics   

                                5.3.2 Research Institute

                                5.3.3 Diagnostic Laboratories     

                5.4 Application                 

                                5.4.1 Medical    

                                5.4.2 Experimental         

                                                5.4.2.1 Western Blot

                                                5.4.2.2 ELISA

                                                5.4.2.3 Radioimmune Assays 

                                                5.4.2.4 Immunofluorescence 

                                                5.4.2.5 Other (Immunohistochemistry, Immunoprecipitation, & Immunocytochemistry)

6. Geographical Analysis                                              

                6.1 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.2 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy           

                                6.2.6 France      

                6.3 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan        

                                6.3.5 South Korea           

                                6.3.6 Australia  

                6.4 Latin America                            

                                6.4.1 Introduction           

                                6.4.2 Brazil         

                                6.4.3 Argentina

                                6.4.4 Mexico     

                6.5 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa        

7. Pipeline Product Analysis                                        

                7.1 Overview                    

                7.2 Pipeline Development Landscape                     

                7.3 Molecular Targets in the Pipeline                      

                7.4 Clinical Trials                              

                                7.4.1 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target                

                                7.4.2 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target               

                7.5 Key Trends in Monoclonal Antibodies Development                 

                                7.5.1 Targeted Therapies             

                7.6 Promising Monoclonal Antibodies in Pipeline                              

                7.7 Heat Map of Safety and Efficacy for Pipeline and Marketed Monoclonal Antibodies                   

8.Strategic Analysis                                        

                8.1 PESTLE analysis                         

                                8.1.1 Political     

                                8.1.2 Economic 

                                8.1.3 Social         

                                8.1.4 Technological         

                                8.1.5 Legal          

                                8.1.6 Environmental      

                8.2 Porter’s Five analysis                              

                                8.2.1 Bargaining Power of Suppliers        

                                8.2.2 Bargaining Power of Consumers    

                                8.2.3 Threat of New Entrants     

                                8.2.4 Threat of Substitute Products and Services

                                8.2.5 Competitive Rivalry within the Industry      

9.Market Leaders' Analysis                                          

                9.1 GlaxoSmithKline plc (U.K.)                   

                                9.1.1 Overview

                                9.1.2 Product Analysis   

                                9.1.3 Financial analysis  

                                9.1.4 Recent Developments       

                                9.1.5 SWOT analysis       

                                9.1.6 Analyst View          

                9.2 Novartis AG (Switzerland)                    

                9.3 Pfizer Inc. (U.S.)                       

                9.4 Thermo Fisher Scientific Inc. (U.S.)                   

                9.5 Eli Lilly and Company (U.S.)                 

                9.6 Seattle Genetics (U.S.)                          

                9.7 Bristol-Myers Squibb (U.S.)                 

                9.8 F. Hoffmann-La Roche Ltd. (Switzerland)                       

                9.9 Biogen Inc.(U.S.)                      

10.Competitive Landscape                                          

                10.1 Market share analysis                          

                10.2 Merger and Acquisition Analysis                     

                10.3 Agreements, collaborations and Joint Ventures                       

                10.4 New Product Launches                       

11.Market Outlook & Investment Opportunities                               

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Monoclonal Antibodies Market By Region, From 2019-2024 ( USD Million )
  2. Global Monoclonal Antibodies Market By Murine, From 2019-2024 ( USD Million )
  3. Global Chimeric Market By Region, From 2019-2024 ( USD Million )
  4. Global Humanized Market By Region, From 2019-2024 ( USD Million )
  5. Global Human Market By Region, From 2019-2024 ( USD Million )
  6. Global Monoclonal Antibodies Market By Cancer, From 2019-2024 ( USD Million )
  7. Global Autoimmune Diseases Market By Region, From 2019-2024 ( USD Million )
  8. Global Infectious Diseases Market By Region, From 2019-2024 ( USD Million )
  9. Global Cardiovascular Diseases Market By Region, From 2019-2024 ( USD Million )
  10. Global CNS Disorders Market By Region, From 2019-2024 ( USD Million )
  11. Global Others (Inflammatory, Microbial Diseases, & Other) Market By Region, From 2019-2024 ( USD Million )
  12. Global Monoclonal Antibodies Market By Hospitals/Clinics, From 2019-2024 ( USD Million )
  13. Global Research Institute Market By Region, From 2019-2024 ( USD Million )
  14. Global Diagnostic Laboratories Market By Region, From 2019-2024 ( USD Million )
  15. Global Monoclonal Antibodies Market By Medical, From 2019-2024 ( USD Million )
  16. Global Experimental Market By Region, From 2019-2024 ( USD Million )
  17. Global Monoclonal Antibodies Market By Blood Cancer, From 2019-2024 ( USD Million )
  18. Global Breast Cancer Market By Region, From 2019-2024 ( USD Million )
  19. Global Colorectal Cancer Market By Region, From 2019-2024 ( USD Million )
  20. Global Lung Cancer Market By Region, From 2019-2024 ( USD Million )
  21. Global Pancreatic Cancer Market By Region, From 2019-2024 ( USD Million )
  22. Global Others Market By Region, From 2019-2024 ( USD Million )
  23. Global Monoclonal Antibodies Market By Western Blot, From 2019-2024 ( USD Million )
  24. Global ELISA Market By Region, From 2019-2024 ( USD Million )
  25. Global Radioimmune Assays Market By Region, From 2019-2024 ( USD Million )
  26. Global Immunofluorescence Market By Region, From 2019-2024 ( USD Million )
  27. Global Others Market By Region, From 2019-2024 ( USD Million )
  28. North America Monoclonal Antibodies Market By Murine, From 2019-2024 ( USD Million )
  29. North America Chimeric Market By Region, From 2019-2024 ( USD Million )
  30. North America Humanized Market By Region, From 2019-2024 ( USD Million )
  31. North America Human Market By Region, From 2019-2024 ( USD Million )
  32. North America Monoclonal Antibodies Market By Cancer, From 2019-2024 ( USD Million )
  33. North America Autoimmune Diseases Market By Region, From 2019-2024 ( USD Million )
  34. North America Infectious Diseases Market By Region, From 2019-2024 ( USD Million )
  35. North America Cardiovascular Diseases Market By Region, From 2019-2024 ( USD Million )
  36. North America CNS Disorders Market By Region, From 2019-2024 ( USD Million )
  37. North America Others (Inflammatory, Microbial Diseases, & Other) Market By Region, From 2019-2024 ( USD Million )
  38. North America Monoclonal Antibodies Market By Hospitals/Clinics, From 2019-2024 ( USD Million )
  39. North America Research Institute Market By Region, From 2019-2024 ( USD Million )
  40. North America Diagnostic Laboratories Market By Region, From 2019-2024 ( USD Million )
  41. North America Monoclonal Antibodies Market By Medical, From 2019-2024 ( USD Million )
  42. North America Experimental Market By Region, From 2019-2024 ( USD Million )
  43. United States Monoclonal Antibodies Market By Murine, From 2019-2024 ( USD Million )
  44. United States Monoclonal Antibodies Market By Cancer, From 2019-2024 ( USD Million )
  45. United States Monoclonal Antibodies Market By Hospitals/Clinics, From 2019-2024 ( USD Million )
  46. United States Monoclonal Antibodies Market By Medical, From 2019-2024 ( USD Million )
  47. Canada Monoclonal Antibodies Market By Murine, From 2019-2024 ( USD Million )
  48. Canada Monoclonal Antibodies Market By Cancer, From 2019-2024 ( USD Million )
  49. Canada Monoclonal Antibodies Market By Hospitals/Clinics, From 2019-2024 ( USD Million )
  50. Canada Monoclonal Antibodies Market By Medical, From 2019-2024 ( USD Million )
  51. North America Monoclonal Antibodies Market By Blood Cancer, From 2019-2024 ( USD Million )
  52. North America Breast Cancer Market By Region, From 2019-2024 ( USD Million )
  53. North America Colorectal Cancer Market By Region, From 2019-2024 ( USD Million )
  54. North America Lung Cancer Market By Region, From 2019-2024 ( USD Million )
  55. North America Pancreatic Cancer Market By Region, From 2019-2024 ( USD Million )
  56. North America Others Market By Region, From 2019-2024 ( USD Million )
  57. United States Monoclonal Antibodies Market By Blood Cancer, From 2019-2024 ( USD Million )
  58. Canada Monoclonal Antibodies Market By Blood Cancer, From 2019-2024 ( USD Million )
  59. North America Monoclonal Antibodies Market By Western Blot, From 2019-2024 ( USD Million )
  60. North America ELISA Market By Region, From 2019-2024 ( USD Million )
  61. North America Radioimmune Assays Market By Region, From 2019-2024 ( USD Million )
  62. North America Immunofluorescence Market By Region, From 2019-2024 ( USD Million )
  63. North America Others Market By Region, From 2019-2024 ( USD Million )
  64. United States Monoclonal Antibodies Market By Western Blot, From 2019-2024 ( USD Million )
  65. Canada Monoclonal Antibodies Market By Western Blot, From 2019-2024 ( USD Million )
  66. Europe Monoclonal Antibodies Market By Murine, From 2019-2024 ( USD Million )
  67. Europe Chimeric Market By Region, From 2019-2024 ( USD Million )
  68. Europe Humanized Market By Region, From 2019-2024 ( USD Million )
  69. Europe Human Market By Region, From 2019-2024 ( USD Million )
  70. Europe Monoclonal Antibodies Market By Cancer, From 2019-2024 ( USD Million )
  71. Europe Autoimmune Diseases Market By Region, From 2019-2024 ( USD Million )
  72. Europe Infectious Diseases Market By Region, From 2019-2024 ( USD Million )
  73. Europe Cardiovascular Diseases Market By Region, From 2019-2024 ( USD Million )
  74. Europe CNS Disorders Market By Region, From 2019-2024 ( USD Million )
  75. Europe Others (Inflammatory, Microbial Diseases, & Other) Market By Region, From 2019-2024 ( USD Million )
  76. Europe Monoclonal Antibodies Market By Hospitals/Clinics, From 2019-2024 ( USD Million )
  77. Europe Research Institute Market By Region, From 2019-2024 ( USD Million )
  78. Europe Diagnostic Laboratories Market By Region, From 2019-2024 ( USD Million )
  79. Europe Monoclonal Antibodies Market By Medical, From 2019-2024 ( USD Million )
  80. Europe Experimental Market By Region, From 2019-2024 ( USD Million )
  81. U.K. Monoclonal Antibodies Market By Murine, From 2019-2024 ( USD Million )
  82. U.K. Monoclonal Antibodies Market By Cancer, From 2019-2024 ( USD Million )
  83. U.K. Monoclonal Antibodies Market By Hospitals/Clinics, From 2019-2024 ( USD Million )
  84. U.K. Monoclonal Antibodies Market By Medical, From 2019-2024 ( USD Million )
  85. Germany Monoclonal Antibodies Market By Murine, From 2019-2024 ( USD Million )
  86. Germany Monoclonal Antibodies Market By Cancer, From 2019-2024 ( USD Million )
  87. Germany Monoclonal Antibodies Market By Hospitals/Clinics, From 2019-2024 ( USD Million )
  88. Germany Monoclonal Antibodies Market By Medical, From 2019-2024 ( USD Million )
  89. France Monoclonal Antibodies Market By Murine, From 2019-2024 ( USD Million )
  90. France Monoclonal Antibodies Market By Cancer, From 2019-2024 ( USD Million )
  91. France Monoclonal Antibodies Market By Hospitals/Clinics, From 2019-2024 ( USD Million )
  92. France Monoclonal Antibodies Market By Medical, From 2019-2024 ( USD Million )
  93. Italy Monoclonal Antibodies Market By Murine, From 2019-2024 ( USD Million )
  94. Italy Monoclonal Antibodies Market By Cancer, From 2019-2024 ( USD Million )
  95. Italy Monoclonal Antibodies Market By Hospitals/Clinics, From 2019-2024 ( USD Million )
  96. Italy Monoclonal Antibodies Market By Medical, From 2019-2024 ( USD Million )
  97. Spain Monoclonal Antibodies Market By Murine, From 2019-2024 ( USD Million )
  98. Spain Monoclonal Antibodies Market By Cancer, From 2019-2024 ( USD Million )
  99. Spain Monoclonal Antibodies Market By Hospitals/Clinics, From 2019-2024 ( USD Million )
  100. Spain Monoclonal Antibodies Market By Medical, From 2019-2024 ( USD Million )
  101. Europe Monoclonal Antibodies Market By Blood Cancer, From 2019-2024 ( USD Million )
  102. Europe Breast Cancer Market By Region, From 2019-2024 ( USD Million )
  103. Europe Colorectal Cancer Market By Region, From 2019-2024 ( USD Million )
  104. Europe Lung Cancer Market By Region, From 2019-2024 ( USD Million )
  105. Europe Pancreatic Cancer Market By Region, From 2019-2024 ( USD Million )
  106. Europe Others Market By Region, From 2019-2024 ( USD Million )
  107. U.K. Monoclonal Antibodies Market By Blood Cancer, From 2019-2024 ( USD Million )
  108. Germany Monoclonal Antibodies Market By Blood Cancer, From 2019-2024 ( USD Million )
  109. France Monoclonal Antibodies Market By Blood Cancer, From 2019-2024 ( USD Million )
  110. Italy Monoclonal Antibodies Market By Blood Cancer, From 2019-2024 ( USD Million )
  111. Spain Monoclonal Antibodies Market By Blood Cancer, From 2019-2024 ( USD Million )
  112. Europe Monoclonal Antibodies Market By Western Blot, From 2019-2024 ( USD Million )
  113. Europe ELISA Market By Region, From 2019-2024 ( USD Million )
  114. Europe Radioimmune Assays Market By Region, From 2019-2024 ( USD Million )
  115. Europe Immunofluorescence Market By Region, From 2019-2024 ( USD Million )
  116. Europe Others Market By Region, From 2019-2024 ( USD Million )
  117. U.K. Monoclonal Antibodies Market By Western Blot, From 2019-2024 ( USD Million )
  118. Germany Monoclonal Antibodies Market By Western Blot, From 2019-2024 ( USD Million )
  119. France Monoclonal Antibodies Market By Western Blot, From 2019-2024 ( USD Million )
  120. Italy Monoclonal Antibodies Market By Western Blot, From 2019-2024 ( USD Million )
  121. Spain Monoclonal Antibodies Market By Western Blot, From 2019-2024 ( USD Million )
  122. Asia-Pacific Monoclonal Antibodies Market By Murine, From 2019-2024 ( USD Million )
  123. Asia-Pacific Chimeric Market By Region, From 2019-2024 ( USD Million )
  124. Asia-Pacific Humanized Market By Region, From 2019-2024 ( USD Million )
  125. Asia-Pacific Human Market By Region, From 2019-2024 ( USD Million )
  126. Asia-Pacific Monoclonal Antibodies Market By Cancer, From 2019-2024 ( USD Million )
  127. Asia-Pacific Autoimmune Diseases Market By Region, From 2019-2024 ( USD Million )
  128. Asia-Pacific Infectious Diseases Market By Region, From 2019-2024 ( USD Million )
  129. Asia-Pacific Cardiovascular Diseases Market By Region, From 2019-2024 ( USD Million )
  130. Asia-Pacific CNS Disorders Market By Region, From 2019-2024 ( USD Million )
  131. Asia-Pacific Others (Inflammatory, Microbial Diseases, & Other) Market By Region, From 2019-2024 ( USD Million )
  132. Asia-Pacific Monoclonal Antibodies Market By Hospitals/Clinics, From 2019-2024 ( USD Million )
  133. Asia-Pacific Research Institute Market By Region, From 2019-2024 ( USD Million )
  134. Asia-Pacific Diagnostic Laboratories Market By Region, From 2019-2024 ( USD Million )
  135. Asia-Pacific Monoclonal Antibodies Market By Medical, From 2019-2024 ( USD Million )
  136. Asia-Pacific Experimental Market By Region, From 2019-2024 ( USD Million )
  137. Japan Monoclonal Antibodies Market By Murine, From 2019-2024 ( USD Million )
  138. Japan Monoclonal Antibodies Market By Cancer, From 2019-2024 ( USD Million )
  139. Japan Monoclonal Antibodies Market By Hospitals/Clinics, From 2019-2024 ( USD Million )
  140. Japan Monoclonal Antibodies Market By Medical, From 2019-2024 ( USD Million )
  141. China Monoclonal Antibodies Market By Murine, From 2019-2024 ( USD Million )
  142. China Monoclonal Antibodies Market By Cancer, From 2019-2024 ( USD Million )
  143. China Monoclonal Antibodies Market By Hospitals/Clinics, From 2019-2024 ( USD Million )
  144. China Monoclonal Antibodies Market By Medical, From 2019-2024 ( USD Million )
  145. India Monoclonal Antibodies Market By Murine, From 2019-2024 ( USD Million )
  146. India Monoclonal Antibodies Market By Cancer, From 2019-2024 ( USD Million )
  147. India Monoclonal Antibodies Market By Hospitals/Clinics, From 2019-2024 ( USD Million )
  148. India Monoclonal Antibodies Market By Medical, From 2019-2024 ( USD Million )
  149. South Korea Monoclonal Antibodies Market By Murine, From 2019-2024 ( USD Million )
  150. South Korea Monoclonal Antibodies Market By Cancer, From 2019-2024 ( USD Million )
  151. South Korea Monoclonal Antibodies Market By Hospitals/Clinics, From 2019-2024 ( USD Million )
  152. South Korea Monoclonal Antibodies Market By Medical, From 2019-2024 ( USD Million )
  153. Australia Monoclonal Antibodies Market By Murine, From 2019-2024 ( USD Million )
  154. Australia Monoclonal Antibodies Market By Cancer, From 2019-2024 ( USD Million )
  155. Australia Monoclonal Antibodies Market By Hospitals/Clinics, From 2019-2024 ( USD Million )
  156. Australia Monoclonal Antibodies Market By Medical, From 2019-2024 ( USD Million )
  157. Asia-Pacific Monoclonal Antibodies Market By Blood Cancer, From 2019-2024 ( USD Million )
  158. Asia-Pacific Breast Cancer Market By Region, From 2019-2024 ( USD Million )
  159. Asia-Pacific Colorectal Cancer Market By Region, From 2019-2024 ( USD Million )
  160. Asia-Pacific Lung Cancer Market By Region, From 2019-2024 ( USD Million )
  161. Asia-Pacific Pancreatic Cancer Market By Region, From 2019-2024 ( USD Million )
  162. Asia-Pacific Others Market By Region, From 2019-2024 ( USD Million )
  163. Japan Monoclonal Antibodies Market By Blood Cancer, From 2019-2024 ( USD Million )
  164. China Monoclonal Antibodies Market By Blood Cancer, From 2019-2024 ( USD Million )
  165. India Monoclonal Antibodies Market By Blood Cancer, From 2019-2024 ( USD Million )
  166. Souh Korea Monoclonal Antibodies Market By Blood Cancer, From 2019-2024 ( USD Million )
  167. Asia-Pacific Monoclonal Antibodies Market By Western Blot, From 2019-2024 ( USD Million )
  168. Asia-Pacific ELISA Market By Region, From 2019-2024 ( USD Million )
  169. Asia-Pacific Radioimmune Assays Market By Region, From 2019-2024 ( USD Million )
  170. Asia-Pacific Immunofluorescence Market By Region, From 2019-2024 ( USD Million )
  171. Asia-Pacific Others Market By Region, From 2019-2024 ( USD Million )
  172. Japan Monoclonal Antibodies Market By Western Blot, From 2019-2024 ( USD Million )
  173. China Monoclonal Antibodies Market By Western Blot, From 2019-2024 ( USD Million )
  174. India Monoclonal Antibodies Market By Western Blot, From 2019-2024 ( USD Million )
  175. Souh Korea Monoclonal Antibodies Market By Western Blot, From 2019-2024 ( USD Million )
  176. Latin America Monoclonal Antibodies Market By Murine, From 2019-2024 ( USD Million )
  177. Latin America Chimeric Market By Region, From 2019-2024 ( USD Million )
  178. Latin America Humanized Market By Region, From 2019-2024 ( USD Million )
  179. Latin America Human Market By Region, From 2019-2024 ( USD Million )
  180. Latin America Monoclonal Antibodies Market By Cancer, From 2019-2024 ( USD Million )
  181. Latin America Autoimmune Diseases Market By Region, From 2019-2024 ( USD Million )
  182. Latin America Infectious Diseases Market By Region, From 2019-2024 ( USD Million )
  183. Latin America Cardiovascular Diseases Market By Region, From 2019-2024 ( USD Million )
  184. Latin America CNS Disorders Market By Region, From 2019-2024 ( USD Million )
  185. Latin America Others (Inflammatory, Microbial Diseases, & Other) Market By Region, From 2019-2024 ( USD Million )
  186. Latin America Monoclonal Antibodies Market By Hospitals/Clinics, From 2019-2024 ( USD Million )
  187. Latin America Research Institute Market By Region, From 2019-2024 ( USD Million )
  188. Latin America Diagnostic Laboratories Market By Region, From 2019-2024 ( USD Million )
  189. Latin America Monoclonal Antibodies Market By Medical, From 2019-2024 ( USD Million )
  190. Latin America Experimental Market By Region, From 2019-2024 ( USD Million )
  191. Brazil Monoclonal Antibodies Market By Murine, From 2019-2024 ( USD Million )
  192. Brazil Monoclonal Antibodies Market By Cancer, From 2019-2024 ( USD Million )
  193. Brazil Monoclonal Antibodies Market By Hospitals/Clinics, From 2019-2024 ( USD Million )
  194. Brazil Monoclonal Antibodies Market By Medical, From 2019-2024 ( USD Million )
  195. Argentina Monoclonal Antibodies Market By Murine, From 2019-2024 ( USD Million )
  196. Argentina Monoclonal Antibodies Market By Cancer, From 2019-2024 ( USD Million )
  197. Argentina Monoclonal Antibodies Market By Hospitals/Clinics, From 2019-2024 ( USD Million )
  198. Argentina Monoclonal Antibodies Market By Medical, From 2019-2024 ( USD Million )
  199. Mexico Monoclonal Antibodies Market By Murine, From 2019-2024 ( USD Million )
  200. Mexico Monoclonal Antibodies Market By Cancer, From 2019-2024 ( USD Million )
  201. Mexico Monoclonal Antibodies Market By Hospitals/Clinics, From 2019-2024 ( USD Million )
  202. Mexico Monoclonal Antibodies Market By Medical, From 2019-2024 ( USD Million )
  203. Latin America Monoclonal Antibodies Market By Blood Cancer, From 2019-2024 ( USD Million )
  204. Latin America Breast Cancer Market By Region, From 2019-2024 ( USD Million )
  205. Latin America Colorectal Cancer Market By Region, From 2019-2024 ( USD Million )
  206. Latin America Lung Cancer Market By Region, From 2019-2024 ( USD Million )
  207. Latin America Pancreatic Cancer Market By Region, From 2019-2024 ( USD Million )
  208. Latin America Others Market By Region, From 2019-2024 ( USD Million )
  209. Brazil Monoclonal Antibodies Market By Blood Cancer, From 2019-2024 ( USD Million )
  210. Argentina Monoclonal Antibodies Market By Blood Cancer, From 2019-2024 ( USD Million )
  211. Mexico Monoclonal Antibodies Market By Blood Cancer, From 2019-2024 ( USD Million )
  212. Latin America Monoclonal Antibodies Market By Western Blot, From 2019-2024 ( USD Million )
  213. Latin America ELISA Market By Region, From 2019-2024 ( USD Million )
  214. Latin America Radioimmune Assays Market By Region, From 2019-2024 ( USD Million )
  215. Latin America Immunofluorescence Market By Region, From 2019-2024 ( USD Million )
  216. Latin America Others Market By Region, From 2019-2024 ( USD Million )
  217. Brazil Monoclonal Antibodies Market By Western Blot, From 2019-2024 ( USD Million )
  218. Argentina Monoclonal Antibodies Market By Western Blot, From 2019-2024 ( USD Million )
  219. Mexico Monoclonal Antibodies Market By Western Blot, From 2019-2024 ( USD Million )
  220. Middle East & Africa Monoclonal Antibodies Market By Murine, From 2019-2024 ( USD Million )
  221. Middle East & Africa Chimeric Market By Region, From 2019-2024 ( USD Million )
  222. Middle East & Africa Humanized Market By Region, From 2019-2024 ( USD Million )
  223. Middle East & Africa Human Market By Region, From 2019-2024 ( USD Million )
  224. Middle East & Africa Monoclonal Antibodies Market By Cancer, From 2019-2024 ( USD Million )
  225. Middle East & Africa Autoimmune Diseases Market By Region, From 2019-2024 ( USD Million )
  226. Middle East & Africa Infectious Diseases Market By Region, From 2019-2024 ( USD Million )
  227. Middle East & Africa Cardiovascular Diseases Market By Region, From 2019-2024 ( USD Million )
  228. Middle East & Africa CNS Disorders Market By Region, From 2019-2024 ( USD Million )
  229. Middle East & Africa Others (Inflammatory, Microbial Diseases, & Other) Market By Region, From 2019-2024 ( USD Million )
  230. Middle East & Africa Monoclonal Antibodies Market By Hospitals/Clinics, From 2019-2024 ( USD Million )
  231. Middle East & Africa Research Institute Market By Region, From 2019-2024 ( USD Million )
  232. Middle East & Africa Diagnostic Laboratories Market By Region, From 2019-2024 ( USD Million )
  233. Middle East & Africa Monoclonal Antibodies Market By Medical, From 2019-2024 ( USD Million )
  234. Middle East & Africa Experimental Market By Region, From 2019-2024 ( USD Million )
  235. Middle East Monoclonal Antibodies Market By Murine, From 2019-2024 ( USD Million )
  236. Middle East Monoclonal Antibodies Market By Cancer, From 2019-2024 ( USD Million )
  237. Middle East Monoclonal Antibodies Market By Hospitals/Clinics, From 2019-2024 ( USD Million )
  238. Middle East Monoclonal Antibodies Market By Medical, From 2019-2024 ( USD Million )
  239. Africa Monoclonal Antibodies Market By Murine, From 2019-2024 ( USD Million )
  240. Africa Monoclonal Antibodies Market By Cancer, From 2019-2024 ( USD Million )
  241. Africa Monoclonal Antibodies Market By Hospitals/Clinics, From 2019-2024 ( USD Million )
  242. Africa Monoclonal Antibodies Market By Medical, From 2019-2024 ( USD Million )
  243. Middle East & Africa Monoclonal Antibodies Market By Blood Cancer, From 2019-2024 ( USD Million )
  244. Middle East & Africa Breast Cancer Market By Region, From 2019-2024 ( USD Million )
  245. Middle East & Africa Colorectal Cancer Market By Region, From 2019-2024 ( USD Million )
  246. Middle East & Africa Lung Cancer Market By Region, From 2019-2024 ( USD Million )
  247. Middle East & Africa Pancreatic Cancer Market By Region, From 2019-2024 ( USD Million )
  248. Middle East & Africa Others Market By Region, From 2019-2024 ( USD Million )
  249. Middle East Monoclonal Antibodies Market By Blood Cancer, From 2019-2024 ( USD Million )
  250. Africa Monoclonal Antibodies Market By Blood Cancer, From 2019-2024 ( USD Million )
  251. Middle East & Africa Monoclonal Antibodies Market By Western Blot, From 2019-2024 ( USD Million )
  252. Middle East & Africa ELISA Market By Region, From 2019-2024 ( USD Million )
  253. Middle East & Africa Radioimmune Assays Market By Region, From 2019-2024 ( USD Million )
  254. Middle East & Africa Immunofluorescence Market By Region, From 2019-2024 ( USD Million )
  255. Middle East & Africa Others Market By Region, From 2019-2024 ( USD Million )
  256. Middle East Monoclonal Antibodies Market By Western Blot, From 2019-2024 ( USD Million )
  257. Africa Monoclonal Antibodies Market By Western Blot, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample